Exalys Therapeutics, Inc. — Form D

Exalys Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-10. The offering totals $25.0M, of which $4.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2020-04-10
• Form: D
• Accession: 0001382963-20-000075
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $25.0M
• Amount sold: $4.0M
• Remaining: $21.0M
• Investors: 2
• Date of first sale: 2020-04-03
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-364777

Issuer

• Name: Exalys Therapeutics, Inc.
• CIK: 0001808911
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 12481 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
• Phone: (949) 422-9676

Officers, directors & promoters (9)

More

• CIK 1808911 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search